Targeting Notch3 in Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Perspectives

被引：32
|
作者：
Giovannini, Catia [1 ,2 ]
Bolondi, Luigi [1 ,2 ]
Gramantieri, Laura [1 ]
机构：
[1] S Orsola Malpighi Univ Hosp, Ctr Appl Biomed Res CRBA, I-40138 Bologna, Italy
[2] Univ Bologna, Dept Med & Surg Sci, I-40138 Bologna, Italy
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2017年 / 18卷 / 01期
关键词：
Notch; p53; hepatocellular carcinoma (HCC); GAMMA-SECRETASE INHIBITOR; ACUTE LYMPHOBLASTIC-LEUKEMIA; TUMOR-SUPPRESSOR FUNCTION; PANCREATIC-CANCER CELLS; HUMAN BREAST-CANCER; DOWN-REGULATION; SIGNALING PATHWAY; STEM-CELLS; RECEPTOR EXPRESSION; LATERAL INHIBITION;
D O I：
10.3390/ijms18010056
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The Notch signaling pathway is a very conserved system that controls embryonic cell fate decisions and the maintenance of adult stem cells through cell to cell communication. Accumulating evidence support the relevance of Notch signaling in different human diseases and it is one of the most commonly activated signaling pathways in cancer. This review focuses mainly on the role of Notch3 signaling in hepatocellular carcinoma and its potential therapeutic applications against this malignancy. In this regard, the crosstalk between Notch and p53 may play an important role.
引用
收藏
页数：13
相关论文
共 50 条
  • [41] Molecular targeting of CSN5 in human hepatocellular carcinoma: a mechanism of therapeutic response
    Lee, Y-H
    Judge, A. D.
    Seo, D.
    Kitade, M.
    Gomez-Quiroz, L. E.
    Ishikawa, T.
    Andersen, J. B.
    Kim, B-K
    Marquardt, J. U.
    Raggi, C.
    Avital, I.
    Conner, E. A.
    MacLachlan, I.
    Factor, V. M.
    Thorgeirsson, S. S.
    ONCOGENE, 2011, 30 (40) : 4175 - 4184
  • [42] Molecular Mechanisms Underlying Hepatocellular Carcinoma
    Merle, Philippe
    Trepo, Christian
    VIRUSES-BASEL, 2009, 1 (03): : 852 - 872
  • [43] Molecular mechanisms in hepatocellular carcinoma development
    Cha, C
    DeMatteo, RR
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2005, 19 (01) : 25 - 37
  • [44] C/EBPα inhibits hepatocellular carcinoma by reducing Notch3/Hes1/p27 cascades
    Shi, Yi-Chao
    Zhao, Hong
    Yin, Chuan
    Zeng, Xin
    Zhang, Qing
    Xu, Wen-Ping
    Wei, Ji
    Chen, Fei
    Xie, Wei-Fen
    DIGESTIVE AND LIVER DISEASE, 2013, 45 (10) : 844 - 851
  • [45] Upregulated MMP28 in Hepatocellular Carcinoma Promotes Metastasis via Notch3 Signaling and Predicts Unfavorable Prognosis
    Zhou, Jiangfan
    Zheng, Xixi
    Feng, Mei
    Mo, Zhichao
    Shan, Yunfeng
    Wang, Yilin
    Jin, Jing
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2019, 15 (04): : 812 - 825
  • [46] MiRNA-206 SUPPRESSES THE METASTASIS OF OSTEOSARCOMA VIA TARGETING Notch3
    Cai, W-T
    Guan, P.
    Lin, M-X
    Fu, B.
    Wu, B.
    Wu, J.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020, 34 (03): : 775 - 783
  • [47] Notch1 and Notch3 overexpression in young women with papillary serous ovarian carcinoma
    Roh, M. H.
    Liu, J.
    Aster, J. C.
    Matuloins, U. A.
    Hirsch, M. S.
    LABORATORY INVESTIGATION, 2008, 88 : 221A - 221A
  • [48] Notch3 Targeting: A Novel Weapon against Ovarian Cancer Stem Cells
    Ceccarelli, Simona
    Megiorni, Francesca
    Bellavia, Diana
    Marchese, Cinzia
    Screpanti, Isabella
    Checquolo, Saula
    STEM CELLS INTERNATIONAL, 2019, 2019
  • [49] Targeting Angiogenic Genes as a Therapeutic Approach for Hepatocellular Carcinoma
    Wong, Chi Hang
    Wong, Cesar S. C.
    Chan, Stephen L.
    CURRENT GENE THERAPY, 2015, 15 (02) : 97 - 108
  • [50] Notch1 and Notch3 overexpression in young women with papillary serous ovarian carcinoma
    Roh, M. H.
    Liu, J.
    Aster, J. C.
    Matuloins, U. A.
    Hirsch, M. S.
    MODERN PATHOLOGY, 2008, 21 : 221A - 221A
12345